Kindeva Drug Delivery, a global contract development manufacturing organization, completed the merger with Meridian Medical Technologies, a manufacturer of EpiPen and other auto-injector and antidotes products. Kindeva and Meridian are operating companies of Altaris, a healthcare investment firm. Financial terms were not disclosed. "We are incredibly excited about the opportunities that will result from the combination of two companies with deep roots in complex drug delivery. The integrated, complementary offerings of Kindeva and Meridian create a CDMO with a broad portfolio of capabilities and proprietary technology platforms across multiple drug delivery formats, enabling us to serve customers and communities across multiple large and growing end markets," Milton Boyer, Meridian CEO.